Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

2.30
Delayed Data
As of Sep 20
 -0.03 / -1.29%
Today’s Change
1.65
Today|||52-Week Range
5.70
+32.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues7.0M13.9M19.1M23.4M
 
 
 
 
 
Cost of Goods Sold1.8M4.2M6.1M6.7M
 
 
 
 
 
Depreciation And Amortization1.5M2.0M2.1M2.1M
 
 
 
 
 
 
Operating ExpensesGross Income3.7M7.7M11.0M14.5M
 
 
 
 
 
General Expenses40.4M48.7M63.4M55.8M
 
 
 
 
 
Research And Development5.3M6.7M8.2M7.5M
 
 
 
 
 
Total Operating Expenses43.7M54.8M71.6M64.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-36.7M-40.9M-52.4M-41.3M
 
 
 
 
 
Extraordinary Credit86.3M26.0M12.3M6.0M
 
 
 
 
 
Extraordinary Charge-1.0M-2.0M-29.4M-700.0K
 
 
 
 
 
Interest Expense On Debt2.0M2.0M1.2M863.0K
 
 
 
 
 
Other Expenses786.0K-5.6M1.5M6.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income47.7M-24.5M-69.1M-30.5M
 
 
 
 
 
Income Taxes0.00-133.0K0.000.00
 
 
Net Income47.7M-24.6M-69.1M-30.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.6M14.6M14.8M15.2M
 
 
 
 
 
Shares To Calculate EPS Diluted36.6M14.6M14.8M15.2M
 
 
 
 
 
 
Earnings Per ShareEPS$1.12-$1.69-$4.67-$2.00
 
 
 
 
 
EPS Diluted$1.12-$1.69-$4.67-$2.00